Reference no: EM133120907

Here is a contemporary and serious public health and health care issue that policymakers at the national and international levels of government are considering. Last spring, some nations and international organizations have floated the idea to give a waiver to drug coronavirus vaccine makers' patents, i.e.  allowing another company to learn the formula and any other information to assist another drug company make the vaccine on their own, and some say with no remuneration to the inventors of the coronavirus vaccines-an invention that took major resources and intellectual capital to develop. To assist in the understanding of this unconventional policy, I have posted some news stories and commentaries for you to review. You can research this topic on your own to gain enough information to make a substantive post on yet another unprecedented issue related to the COVID-19 pandemic thrust upon the world.

• Do you see the waiver as a good thing? Explain from what perspective?
• Do you see the waiver as something that may be possible, given certain parameters?

Or,

• Do you see the waiver as bad policy and a slippery slope for an industry for which hanging in the balance is life and death?